Recurrent Respiratory Papillomatosis and Bevacizumab Treatment
Am J Respir Crit Care Med
.
2018 Feb 15;197(4):539-541.
doi: 10.1164/rccm.201702-0279LE.
Authors
Sebastian Fernandez-Bussy
1
,
Gonzalo Labarca
2
3
,
Macarena R Vial
1
,
Rodrigo Soto
1
,
Hiren J Mehta
4
,
Michael Jantz
4
,
Adnan Majid
5
,
Mauricio Burotto
6
Affiliations
1
1 Universidad del Desarrollo Santiago, Chile.
2
2 Universidad San Sebastián Concepción, Chile.
3
3 Complejo Asistencial Dr. Víctor Ríos Ruiz Los Ángeles, Chile.
4
4 University of Florida College of Medicine Gainesville, Florida.
5
5 Harvard Medical School Boston, Massachusetts and.
6
6 Universidad del Desarrollo Santiago, Chile.
PMID:
28968150
DOI:
10.1164/rccm.201702-0279LE
No abstract available
Publication types
Letter
Comment
MeSH terms
Bevacizumab
Humans
Papilloma*
Papillomavirus Infections*
Respiratory Tract Infections*
Substances
Bevacizumab
Supplementary concepts
Recurrent respiratory papillomatosis